WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Apparatus and method for noninvasive blood glucose monitoring    
United States Patent5139023   
Link to this pagehttp://www.wikipatents.com/5139023.html
Inventor(s)Stanley; Theodore H. (Salt Lake City, UT); Ebert; Charles D. (Salt Lake City, UT); Higuchi; William I. (Salt Lake City, UT); Zhang; Jie (Salt Lake City, UT)
AbstractThe present invention is directed to novel methods and apparatus for noninvasive blood glucose monitoring. Blood glucose is monitored noninvasively by correlation with amount of glucose which permeates an epithelial membrane, such as skin or a mucosal membrane, into a glucose receiving medium over a specified time period. The glucose receiving medium preferably includes a glucose permeation enhancer capable of increasing the glucose permeability across the epithelial membrane. The glucose receiving medium is positioned against the epithelial membrane so that the permeation enhancer alters the permeability of the membrane. After sufficient time delay, the glucose receiving medium is removed and analyzed for the presence of glucose using conventional analytical techniques. The apparatus within the scope of the present invention includes means for supporting the glucose receiving medium. Such means for supporting the glucose receiving medium may include a housing defining a receiving chamber therein which holds the glucose receiving medium and an opening to the receiving chamber. The means for supporting the glucose receiving medium may also include a hydrogel. The apparatus also preferably includes means for temporarily positioning the glucose receiving medium against the epithelial membrane.



 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5139023
Apparatus and method for noninvasive blood glucose monitoring - US Patent 5139023 Drawing
Apparatus and method for noninvasive blood glucose monitoring
Inventor     Stanley; Theodore H. (Salt Lake City, UT); Ebert; Charles D. (Salt Lake City, UT); Higuchi; William I. (Salt Lake City, UT); Zhang; Jie (Salt Lake City, UT)
Owner/Assignee     TheraTech Inc. (Salt Lake City, UT); Stanley Research Foundation (Salt Lake City, UT)
Patent assignment
All assignments
Publication Date     August 18, 1992
Application Number     07/360,876
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     June 2, 1989
US Classification     600/368 600/573 600/581 604/289 604/290
Int'l Classification     A61B 005/00
Examiner     Rosenbaum; C. Fred
Assistant Examiner     Smith; Chalin
Attorney/Law Firm     Workman, Nydegger & Jensen
Address
Parent Case    
Priority Data    
USPTO Field of Search     128/760 128/767 128/632 128/637 128/763 604/289 604/290 604/304 604/307 604/20 604/896 514/975
Patent Tags     noninvasive blood glucose monitoring
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
2561071



[0 after 0 votes]
3053255



[0 after 0 votes]
3289671



[0 after 0 votes]
3323774



[0 after 0 votes]
3794910



[0 after 0 votes]
4957108
Schoendorfer
600/362
Sep,1990

[0 after 0 votes]
4909256
Peck
600/362
Mar,1990

[0 after 0 votes]
4892737
Bodor
424/449
Jan,1990

[0 after 0 votes]
4889721
Ueda
424/448
Dec,1989

[0 after 0 votes]
4819645
Peck
600/362
Apr,1989

[0 after 0 votes]
4747841
Kuratomi
604/291
May,1988

[0 after 0 votes]
4746508
Carey

May,1988

[0 after 0 votes]
4743249
Loveland
424/447
May,1988

[0 after 0 votes]
4723958
Pope
604/890.1
Feb,1988

[0 after 0 votes]
4710191
Kwiatek
424/449
Dec,1987

[0 after 0 votes]
4706676
Peck
600/362
Nov,1987

[0 after 0 votes]
4693711
Bremer
604/306
Sep,1987

[0 after 0 votes]
4690683
Chien
424/448
Sep,1987

[0 after 0 votes]
4671953
Stanley
424/440
Jun,1987

[0 after 0 votes]
4640689
Sibalis
604/20
Feb,1987

[0 after 0 votes]
4635488
Kremer
73/864.72
Jan,1987

[0 after 0 votes]
4573996
Kwiatek
424/434
Mar,1986

[0 after 0 votes]
4557723
Sibalis
604/20
Dec,1985

[0 after 0 votes]
4548922
Carey
514/4
Oct,1985

[0 after 0 votes]
4542751
Webster
600/573
Sep,1985

[0 after 0 votes]
4542750
Ettare
600/573
Sep,1985

[0 after 0 votes]
4538616
Rogoff
600/365
Sep,1985

[0 after 0 votes]
4458686
Clark, Jr.
600/358
Jul,1984

[0 after 0 votes]
4457748
Lattin
604/20
Jul,1984

[0 after 0 votes]
4401122
Clark, Jr.
600/358
Aug,1983

[0 after 0 votes]
4398543
Sandlin
600/573
Aug,1983

[0 after 0 votes]
4380454
Stadelhofer
44/591
Apr,1983

[0 after 0 votes]
4379454
Campbell
424/448
Apr,1983

[0 after 0 votes]
4364385
Lossef
424/424
Dec,1982

[0 after 0 votes]
4325367
Tapper
604/20
Apr,1982

[0 after 0 votes]
4321252
Keith
514/182
Mar,1982

[0 after 0 votes]
4292299
Suzuki
424/435
Sep,1981

[0 after 0 votes]
4250163
Nagai
514/772.1
Feb,1981

[0 after 0 votes]
4200110
Peterson
600/367
Apr,1980

[0 after 0 votes]
4190060
Greenleaf
600/573
Feb,1980

[0 after 0 votes]
4151832
Hamer
600/578
May,1979

[0 after 0 votes]
4014334
Theeuwes
424/427
Dec,1969

[0 after 0 votes]
4116241
Theeuwes
604/892.1
Dec,1969

[0 after 0 votes]
4622031
Sibalis
604/20
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed and desired to be secured by United States Letters Patent is:

1. An apparatus for noninvasive blood glucose monitoring comprising:

a quantity of glucose receiving medium comprising a permeation enhancer capable of increasing the glucose permeability across an epithelial membrane;

means for supporting the glucose receiving medium comprising a housing defining a receiving chamber therein and an opening to said receiving chamber;

means for temporarily positioning the glucose receiving medium against the epithelial membrane; and

a handle attached to the housing to facilitate positioning of the apparatus against the epithelial membrane and removal of the apparatus.

2. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the means for supporting the glucose receiving medium and the means for temporarily positioning the glucose receiving medium against the mucosal membrane comprise a hydrogel.

3. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the permeation enhancer comprises a natural bile salt.

4. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises water.

5. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises a cream.

6. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises a suspension.

7. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises an emulsion.

8. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises a semisolid composition.

9. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, wherein the glucose receiving medium comprises a composition capable of reacting with glucose to form a substantially insoluble product.

10. An apparatus for noninvasive blood glucose monitoring as defined in claim 1, further comprising means for regulating the glucose permeation rate in order to provide a calibrated permeation rate despite variations in glucose permeation from patient to patient and from time to time.

11. An apparatus for noninvasive blood glucose monitoring comprising:

a quantity of glucose receiving medium comprising a permeation enhancer capable of increasing the glucose permeability across a mucosal membrane within a patient's mouth;

means for supporting the glucose receiving medium;

means for temporarily positioning the glucose receiving medium against the mucosal membrane such that a quantity of glucose, which directly correlates on a real time basis with a patient's actual blood glucose value, is capable of permeating the mucosal membrane into the glucose receiving medium; and

means for preventing contamination of the glucose receiving medium by saliva and other fluids present in the patient's mouth.

12. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the means for supporting the glucose receiving medium comprises a housing defining a receiving chamber therein and an opening to said receiving chamber.

13. An apparatus for noninvasive blood glucose monitoring comprising:

a quantity of glucose receiving medium comprising a permeation enhancer capable of increasing the glucose permeability across a mucosal membrane;

means for supporting the glucose receiving medium comprising a housing defining a receiving chamber therein and an opening to said receiving chamber;

means for temporarily positioning the glucose receiving medium against the mucosal membrane; and

a handle attached to the housing to facilitate positioning of the apparatus against the mucosal membrane and removal of the apparatus.

14. An apparatus for noninvasive blood glucose monitoring as defined in claim 12, further comprising means for accessing the receiving chamber such that glucose receiving medium may be introduced into the receiving chamber or removed therefrom while the housing is positioned against the mucosal membrane.

15. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the means for supporting the glucose receiving medium and the means for temporarily positioning the glucose receiving medium against the mucosal membrane comprise a hydrogel.

16. An apparatus for noninvasive blood glucose monitoring as defined in claim 15, wherein the hydrogel comprises hydroxypropylcellulose.

17. An apparatus for noninvasive blood glucose monitoring as defined in claim 15, wherein the hydrogel comprises carbopol.

18. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a natural bile salt.

19. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises sodium cholate.

20. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises sodium dodecyl sulfate.

21. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises sodium deoxycholate.

22. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises taurodeoxycholate.

23. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises sodium glycocholate.

24. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a fatty acid.

25. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a saturated fatty acid.

26. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises an unsaturated fatty acid.

27. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a surfactant.

28. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises an ionic surfactant.

29. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a nonionic surfactant.

30. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the permeation enhancer comprises a synthetic permeation enhancer.

31. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises water.

32. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises a cream.

33. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises a suspension.

34. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises an emulsion.

35. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises a semisolid composition.

36. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, wherein the glucose receiving medium comprises a composition capable of reacting with glucose to form a substantially insoluble product.

37. An apparatus for noninvasive blood glucose monitoring as defined in claim 11, further comprising means for regulating the glucose permeation rate in order to provide a calibrated permeation rate desp